According to Lifecore Biomedical's latest financial reports the company's current EPS (TTM) is -$5.76. In 2022 the company made an earnings per share (EPS) of -$4.32 a decrease over its 2021 EPS that were of -$3.29.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.45 | 26.32% |
2022 | -$4.32 | 31.06% |
2021 | -$3.29 | 9.92% |
2020 | -$3.00 | 371.1% |
2019 | -$0.64 | -146.7% |
2018 | $1.36 | 150.96% |
2017 | $0.54 | -171.58% |
2016 | -$0.76 | -192.77% |
2015 | $0.82 | -23.31% |
2014 | $1.07 | -7.88% |
2013 | $1.16 | -9.22% |
2012 | $1.27 | 289.13% |
2011 | $0.33 | 11.14% |
2010 | $0.29 | -39.17% |
2009 | $0.48 | -37.54% |
2008 | $0.78 | -67.39% |
2007 | $2.38 | 236.13% |
2006 | $0.71 | 71.07% |
2005 | $0.41 | 41.18% |
2004 | $0.29 | 1600% |
2003 | $0.01724 | -109.09% |
2002 | -$0.19 | -76.6% |
2001 | -$0.81 | 213.33% |
2000 | -$0.26 | -25% |
1999 | -$0.34 | -13.04% |
1998 | -$0.40 | -70.13% |
1997 | -$1.33 | 33.36% |
1996 | -$1.00 |